![Header2.png](https://static.wixstatic.com/media/7305f4_614cd8cef2e74df6bc49e82ff8e4c4ab~mv2.png/v1/fill/w_18,h_6,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/7305f4_614cd8cef2e74df6bc49e82ff8e4c4ab~mv2.png)
Generators
Generators
Tc-99m Generator
Sodium molybdate (Mo-99) 2.5- 60 GBq corresponding to Sodium pertechnetate (Tc-99m) 2 - 50 GBq, radionuclide generator
A technetium-99m generator, also known as a technetium, is a device used to extract the metastable isotope 99mTc of technetium from a decaying sample of molybdenum-99. 99Mo has a half-life of 66 hours[1] and can be transported over long distances to hospitals where its decay product technetium-99m is extracted and used for a variety of nuclear medicine diagnostic procedures.
![Tekcis-Generateur.png](https://static.wixstatic.com/media/7305f4_e3c5c6d0823741ef88e18da9a7c8511f~mv2.png/v1/crop/x_191,y_106,w_892,h_915/fill/w_55,h_56,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/Tekcis-Generateur.png)
Rhenium-188 is a beta-emitter with a 16.98-hour half-life, it may form complexes. It allows synthesizing radiopharmaceuticals for diagnostics and therapy of malignant tumors, bone metastases, rheumatoid arthritis and other diseases. The parent isotope is Tungsten-188.
​
The advantage of this generator is the presence of both beta- and gamma- radiation components (0.155 MeV); the first of these ensures a high therapeutic effect and the second one enables the operators to receive visual information in conventional gamma-cameras.
![25.png](https://static.wixstatic.com/media/7305f4_3cdbcdf278b1482984189363d07ee6bc~mv2.png/v1/crop/x_510,y_0,w_558,h_500/fill/w_62,h_56,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/25.png)
Rhenium - 188 Generator
Characteristics
Manufacturing enterprise: IPPE.
Parent isotope's activity: 3,7; 5,5; 7,4; 18,5; 37,0 GBq.
Generator's weight: 16 kg (without package).
Lifetime: 40, 80, 110, 150, 200 days (depending on the generator's type).
Technical advantages
-
Short half-life period of Re-188 (17 hours) makes it safer for patients, staff and environment.
-
The presence of mean energy β-emission provides an optimal therapeutic dose for affecting pathology focus (tumors and other).
-
The presence of a γ-component with the energy of 155 keV in the emission spectrum makes it possible to monitor the behavior of the labeled pharmaceutical in the patient's body using SPECT.
-
Produced under Radiation Safety Standards-2009/2010.
-
The half-life period of parent W-188 radionuclide (69,4 days) makes it possible to use one generator within 6 to 12 months (depending on the generator rated activity).